ANIXA BIOSCIENCES, INC. Equity Method Investment, Ownership Percentage
ANIXA BIOSCIENCES, INC. (ANIX) had Equity Method Investment, Ownership Percentage of 5.00% as of 2022-04-30, per its 10-Q filed 2022-06-10.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-06-10
- 2022-04-30: Equity Method Investment, Ownership Percentage 5.00%.
- 2022-01-31: Equity Method Investment, Ownership Percentage 5.00%.
- 2021-10-31: Equity Method Investment, Ownership Percentage 5.00%.
- 2020-04-30: Equity Method Investment, Ownership Percentage 5.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2022-04-30 | 5.00% 10-Q · filed 2022-06-10 |
| 2022-01-31 | 5.00% 10-Q · filed 2022-03-11 |
| 2021-10-31 | 5.00% 10-K · filed 2022-01-04 |
| 2020-04-30 | 5.00% 10-Q · filed 2020-06-09 |
| 2020-01-31 | 5.00% 10-Q · filed 2020-03-09 |
| 2019-10-31 | 5.00% 10-K · filed 2020-01-09 |
| 2019-07-31 | 5.00% 10-Q · filed 2019-09-06 |
| 2019-04-30 | 5.00% 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |